1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Patient summary
Patient Sex/Age (y) Time from First Symptom (y) Time from Diagnosis (y) Time from First ON Symptom (y) Medication 1 F/49 34 10 32 Interferon beta-1a 2 F/38 10 8 10 None 3 F/48 10 8 8 None 4 F/33 10 0.5 10 Interferon beta-beta-1b 5 F/45 13 10 13 Glatiramer acetate 6 F/34 1.5 1 1 Interferon beta-1a 7 F/40 17 15 5 None 8 M/39 1.5 1 1.5 Glatiramer acetate 9 F/44 1 0.5 1 Interferon beta-1a Mean β/41.1 10.9 6.0 9.1 SD β/5.7 10.3 5.4 9.7
Note.βON indicates optic neuritis.